Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus non-structural protein 2 (NSP2) is a multifunctional protein essential for the replication and assembly of rotaviruses, the primary cause of severe dehydrating diarrhea in children (UniProt P04510). It functions as an octameric enzyme with nucleoside triphosphatase (NTPase), RNA triphosphatase (RTPase), and RNA chaperone activities (PubMed: 11832544). NSP2 is a key driver in the formation of viroplasms, which are cytoplasmic inclusion bodies that serve as viral factories for RNA synthesis and early particle assembly (PubMed: 15140983). Within these structures, NSP2 interacts with the non-structural protein NSP5 and viral RNA to facilitate the selection and packaging of the eleven segments of the viral genome. Its helix-destabilizing activity is thought to assist in the movement of RNA templates during replication. As a central hub for viral morphogenesis, NSP2 is a high-priority target for the development of direct-acting antivirals. Inhibition of NSP2 could potentially halt viral production by preventing viroplasm assembly or disrupting genome packaging. While no drugs targeting NSP2 are currently FDA-approved, research into small molecule inhibitors and RNA interference strategies is ongoing to address the global burden of rotavirus disease.
Inhibition of viral replication by disrupting viroplasm assembly, RNA chaperone activity, or NTPase-mediated energy transduction required for genome packaging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus non-structural protein 2 (NSP2).